Explore the words cloud of the KOALA FOCUS project. It provides you a very rough idea of what is the project "KOALA FOCUS" about.
The following table provides information about the project.
Coordinator |
MENSIA TECHNOLOGIES
Organization address contact info |
Coordinator Country | France [FR] |
Total cost | 71˙429 € |
EC max contribution | 50˙000 € (70%) |
Programme |
1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies) |
Code Call | H2020-SMEInst-2018-2020-1 |
Funding Scheme | SME-1 |
Starting year | 2019 |
Duration (year-month-day) | from 2019-05-01 to 2019-08-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | MENSIA TECHNOLOGIES | FR (CHANTEPIE) | coordinator | 50˙000.00 |
Attention Deficit with/without Hyperactivity Disorders (ADHD) is a neurological disorder with a high societal impact: 2.5 M children are diagnosed, and 2-5 M Adults in Europe are non-diagnosed. 50% children are not medicated mainly due to drug refusal and high rate under medication face adverse effects and treatment rejection. Mensia has developed a revolutionary prototype, Mensia KOALA, to treat ADHD by means of neurofeedback at home and without drugs, using Artificial Intelligence techniques. Our new prototype version “KOALA Focus” aims to be the first affordable Gold Standard Medical Device for Precise Medical Neurofeedback friendly used at home, whatever the patient's age. Our prototype, currently at TRL6, is a breakthrough innovation thanks to disruptive combination: at home evidence based medical neurofeedback technology, the first reliable non-invasive and precise e-Health Digital Therapeutic, monitoring and treating various types of ATTENTION DEFICITS. Our business model is based on buy hardware cap via secured eHealth Mensia platform and pay per at home session. The ADHD therapeutic market is estimated to reach €21.5 B by 2024 growing at a CAGR of 6.2%. TOTAL ATTENTION DEFICIT market in Europe worth 5 M individuals. KOALA Focus, once validated by the appropriate clinical trials, can achieve up to 50% of regular prescribers from this addressable market in the EU. Mensia aim to set up a Gold Standard of Good Clinical Practices for Precise Medical Neurofeedback at home, capturing 20% (1 M individuals) of this addressable market: 2,5 M children EU 2,5 M adults. We estimated that in 5 years (end of Phase 2 project), we will accumulate ~€120 M of Revenues at 40€ /session, accounting for ~5% of the EU market, earning ~€36M profit (ROI of 5.7), while hiring 60 new technical and sales employees.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "KOALA FOCUS" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "KOALA FOCUS" are provided by the European Opendata Portal: CORDIS opendata.
Tracworx is a data analytics tool that allows you to establish bottlenecks in your patient flow, while understanding your efficiencies and ultimately your true capacity.
Read MoreMANUBACK, the smart garment for operator protection in the field of Manual Handling of Goods
Read More